Differences in progression to esrd between black and white patients receiving predialysis care in a universal health care system

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 9, 2013, Pages 1540-1547

  van den Beukel, Tessa O ^a,b   de Goeij, Moniek C M ^a   Dekker, Friedo W ^a   Siegert, Carl E H ^b   Halbesma, Nynke ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE SYSTEM; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; RACE DIFFERENCE; SENSITIVITY ANALYSIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; DIABETES MELLITUS; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEALTH STATUS DISPARITIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NETHERLANDS; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; UNIVERSAL COVERAGE;

EID: 84883705410     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10761012     Document Type: Article

References (46)

1. U S Renal Data System: USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, Na- tional Institute of Diabetes and Digestive and Kidney Diseases, 2011
2. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Hernandez GT, O'Hare AM: White/black racial differences in risk of end-stage renal disease and death. Am J Med 122: 672-678, 2009
3. Hall YN, Hsu CY, Iribarren C, Darbinian J, McCulloch CE, Go AS: The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int 68: 2310-2316, 2005
4. Hsu CY, Lin F, Vittinghoff E, Shlipak MG: Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14: 2902-2907, 2003
5. Norris K, Nissenson AR: Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 19: 1261-1270, 2008
6. Norris K, Mehrotra R, Nissenson AR: Racial differences in mortality and ESRD. Am J Kidney Dis 52: 205-208, 2008
7. August P, Suthanthiran M: Transforming growth factor beta and progression of renal disease. Kidney Int Suppl Nofi: S99-S104, 2003
8. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845, 2010
9. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS; Family Investigation of Nephropathy and Diabetes Research Group: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-1192, 2008
10. Barbour SJ, Schachter M, Er L, Djurdjev O, Levin A: A systematic review of ethnic differences in the rate of renal progression in CKD patients. Nephrol Dial Transplant 25: 2422-2430, 2010
11. Mayberry RM, Mili F, Ofili E: Racial and ethnic differences in access to medical care. Med Care Res Rev 57[Suppl 1]: 108-145, 2000
12. Popescu I, Vaughan-Sarrazin MS, Rosenthal GE: Differences in mortality and use of revascularization in black and white patients with acute MI admitted to hospitals with and without revascularization services. JAMA 297: 2489-2495, 2007
13. Li S, McAlpine DD, Liu J, Li S, Collins AJ: Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther 11: 5-13, 2004
14. Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ: Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol 18: 1299-1306, 2007
15. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM: Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol 18: 2968-2974, 2007
16. Veenema T, Wiegers T, Devillé W: Toegankelijkheid van gezondheidszorg voor'illegalen' in Nederland: een update, Utrecht, NIVEL, 2009
17. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[Suppl 1]: S1-S266, 2002
18. Nederlandse Federatie voor Nefrologie. Dutch multidisciplinary guideline predialysis. 2011. Available at: http://www.nefro.nl/home/richtlijnen/richtlijnen/multidisciplinaire-richtlijn-predialyseupdate-2011?objectSynopsis=NYEejTw7JyN9kuOSMchyZg#NatU4T_ONZsM4jydrUPYGg. Accessed April 2013.
19. Organisation for Economic Co-operation and Development. International Migration Outlook: Annual Report 2008 Edition. 2008. Available at: http://www.oecd.org/els/mig/internationalmigrationoutlook2008.htm. Accessed April 2013
20. Registry ERA-EDTA: Appendix 1 Grouping of primary rena diseases. In: ERA-EDTA Registry Annual Report 2008, Amsterdam, The Netherlands, Academic Medical Center, Department of Medical Informatics, 2010, p 126
21. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2003
22. Jager KJ, van Dijk PC, Zoccali C, Dekker FW: The analysis of survival data: The Kaplan-Meier method. Kidney Int 74: 560-565, 2008
23. Southern DA, Faris PD, Brant R, Galbraith PD, Norris CM, Knudtson ML, Ghali WA; APPROACH Investigators: Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol 59: 1110-1114, 2006
24. FitzMaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis, Hoboken, New Jersey, John Wiley & Sons, Inc., 2011
25. Donders AR, van der Heijden GJ, Stijnen T, Moons KG: Review: A gentle introduction to imputation of missing values. J Clin Epidemiol 59: 1087-1091, 2006
26. Greenland S, Finkle WD: A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 142: 1255-1264, 1995
27. van Buuren S, Boshuizen HC, Knook DL: Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18: 681-694, 1999
28. Moons KG, Donders RA, Stijnen T, Harrell FE Jr: Using the out-come for imputation of missing predictor values was preferred. J Clin Epidemiol 59: 1092-1101, 2006
29. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, Kusek JW, Byrd-Holt D, Narayan KM, Herman WH, Jones CP, Salive M, Agodoa LY: Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 39: 445-459, 2002
30. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
31. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS: Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169: 342-350, 2009
32. Earle KK, Porter KA, Ostberg J, Yudkin JS: Variation in the progression of diabetic nephropathy according to racial origin. Nephrol Dial Transplant 16: 286-290, 2001
33. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908-1919, 1997
34. Kovesdy CP, Anderson JE, Derose SF, Kalantar-Zadeh K: Outcomes associated with race in males with nondialysisdependent chronic kidney disease. Clin J Am Soc Nephrol 4: 973-978, 2009
35. Newsome BB, McClellan WM, Allison JJ, Eggers PW, Chen SC, Collins AJ, Kiefe CI, Coffey CS, Warnock DG: Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction. Am J Kidney Dis 52: 251-261, 2008
36. Bhopal R: Glossary of terms relating to ethnicity and race: For reflection and debate. J Epidemiol Community Health 58: 441-445, 2004
37. Armas LA, Dowell S, Akhter M, Duthuluru S, Huerter C, Hollis BW, Lund R, Heaney RP: Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: The effect of UVB dose and skin color. J Am Acad Dermatol 57: 588-593, 2007
38. Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P: 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 20: 2631-2639, 2009
39. Wu-Wong JR, Nakane M, Ma J: Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells. J Vasc Res 44: 11-18, 2007
40. Lopes AA, Port FK: The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, noninsulin-dependent diabetes, and end-stage renal disease. Am J Kidney Dis 25: 350-356, 1995
41. Sijpkens YWJ, Berkhout-Byrne NC, Rabelink TJ: Optimal predialysis care. Nephrol Dial Transplant Plus 1: 7-13, 2008
42. Navaneethan SD, Nigwekar S, Sengodan M, Anand E, Kadam S, Jeevanantham V, Grieff M, Choudhry W: Referral to nephrologists for chronic kidney disease care: Is non-diabetic kidney disease ignored? Nephron Clin Pract 106: c113-c118, 2007
43. Winkelmayer WC, Glynn RJ, Levin R, Owen WF Jr, Avorn J: Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis 38: 1178-1184, 2001
44. Goldwasser P, Aboul-Magd A, Maru M: Race and creatinine excretion in chronic renal insufficiency. Am J Kidney Dis 30: 16-22, 1997
45. Hsu CY, Chertow GM, Curhan GC: Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 61: 1567-1576, 2002
46. Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Phillips R, Sika M, Wright J Jr; African-American Study of Hypertension and Kidney Disease: Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 38: 744-753, 2001